Cc emccc 2016_2e_ak_6
- 1. 8th European Multidisciplinary Colorectal Cancer Congress WWW.EMCCC2016.ORG 11 - 13 december 2016 RAI Amsterdam, the Netherlands Early Bird Registration deadline: 1 July 2016 Abstract Deadline: 1 Sept. 2016 2nd announcement including scientific programme
- 2. It is our great pleasure to announce the 8th EMCCC 2016! The European Multidisciplinary Colorectal Cancer Congress (EMCCC) is the European conference that truly provides a platform for in-depth multidisciplinary interaction among the various research areas involved.The DutchColorectalCancerGroup (DCCG) has taken the initiative for the EMCCC since 2001.The conference in 2016 builds upon seven previous successful multidisciplinary conferences on colorectal cancer which were held in the Netherlands, Germany, France and Czech Republic. The EMCCC offers an intimate scientific/educational environment for around 700 participants. Colorectal cancer is one of the most common types of malignancies and much progress has been made in recent years in understanding the biology and treatment of this disease.These developments encompass almost the full research area including genetics, biology, pathology/prognostic markers, surgery, screening, systemic treatment, radiotherapy, and imaging.This implies that both pre-clinical and clinical research is becoming much more multidisciplinary oriented. The conference will have separate workshops on surgery, medical oncology, radiotherapy, pathology, imaging, gastroenterology, and genetics, but all other sessions are plenary in order to have optimal interaction between all disciplines.The format of the conference consists of workshops, a keynote lecture, controversy sessions, satellite symposia, and oral and poster presentations on prevention and screening, diagnosis and follow-up, translational research, multidisciplinary management, genetics, evaluation of treatment, and updates on randomized CRC trials. Looking forward meeting you in December in Amsterdam! The EMCCC local organising committee, Prof.dr. C.J.A. (Kees) Punt, medical oncology, congress president Prof.dr. R.G.H. (Regina) Beets-Tan, radiology Prof.dr. N. (Nicoline) Hoogerbrugge-van der Linden, antropogenetics Dr. J. (Jeroen) Buijsen, radiotherapy Prof.dr. G.A. (Gerrit) Meijer, pathology Dr. S. (Silvia) Sanduleanu, gastroenterology Dr. P.J. (Pieter)Tanis, surgery Important dates 1 July 2016 Early registration deadline 1 September 2016 Abstract submission deadline 1October 2016 Abstract notifications mailed 1October 2016 Deadline regular fee 15October 2016 Abstract presenter registration deadline 1 November 2016 Deadline late breaking abstracts* * for information on late breaking abstract requirements see www.emccc2016.org. See the congress website for the latest information: www.emccc2016.org The European MultidisciplinaryColorectalCancerCongres is an initiative from the DutchColorectal CancerGroup (DCCG) en is endoserd by the following assocations: Sponsors & Exhibitors See pages 15 for detailed information Congress secretariat Congress Care PO Box 440 NL-5201 AK ‘s-Hertogenbosch T: +31 (0)73 690 1415 info@congresscare www.congresscare.com Introduction
- 3. CommitteesCommittees Local Organising Committee Prof.dr. C.J.A. (Kees) Punt, medical oncology, congress president Prof.dr. R.G.H. (Regina) Beets-Tan, radiology Prof.dr. N. (Nicoline) Hoogerbrugge-van der Linden, antropogenetics Dr. J. (Jeroen) Buijsen, radiotherapy Prof.dr. G.A. (Gerrit) Meijer, pathology Dr. S. (Silvia) Sanduleanu, gastroenterology Dr. P.J. (Pieter)Tanis, surgery Scientific Committee Surgery P.J.Tanis (the Netherlands) E.Tiret (France, European Society of Coloprectology) G. Beets (the Netherlands, European Society of Digestive Oncology) A. Martling (Sweden, European Society of Coloproctology) D. Morton (United Kingdom, research committee ESCP) G. Romano (Italy, UEG representative ESCP) T. Gruenberger (Austria, ESDO) S. Biondo (Spain, ESCP) Medical Oncology C.J.A. Punt (the Netherlands) D. Arnold (Germany) A. Sobrero (Italy) R. Adams (UK) T. André (France) M. Peeters (Belgium) H. Sorbeye (Norway) Radiation Oncology D. Sebag-Montefiore (United Kingdom) C.A.M. Marijnen (the Netherlands) K. Haustermans (Belgium) C. Rödel (Germany) V.Valentini (Italy) J.P. Gérard (France) K. Bujko (Poland) J. Buijsen (the Netherlands) Gastroenterology E. Dekker (the Netherlands) C. Rees United Kingdom) L. Ricciardiello (Italy) M. Bretthauer (Norway) Imaging R.G.H. Beets-Tan (the Netherlands) A. Laghi (Italy) L. Blomqvist (Sweden) T. Helmberger (Germany) J. Stoker (the Netherlands) M. Stokkel (the Netherlands) S. Halligan (United Kingdom) P. Flamen (Belgium) Genetics N. Hoogerbrugge - van der Linden (the Netherlands) G. Evans (United Kingdom) M. Genuardi (Italy) E. Holinky-Feder (Germany) T. Frebourg (France) R. Sijmons (the Netherlands) M.Tischkowitz (United Kingdom) Pathology G. Meijer (the Netherlands) Ph. Quirke (UK)
- 4. Sunday 11 December Monday 12 December Tuesday 13 December 08.00 Registration Registration 08.00 - 10.00 Interactive computerized radiology workshop Interactive computerized radiology workshop 08.15 Plenary session 1 Plenary session 7 09.30 Plenary session 2 Plenary session 8 10.45 Break Break 11:00 Registration 11.15 Plenary session 3 Plenary session 9 13:00 Workshop round 1 12.30 Lunch & Posters Lunch & Posters 12.45 - 13.45 Sponsored symposium 2 Sponsored symposium 3 14:15 Break 14:00 Key-note lecture Plenary session 10 14:45 Workshop round 2 14:45 Plenary session 4 15.15 Plenary session 5 Plenary session 11 16:00 Sponsored symposium 1 16.00 - 16.30 Break Break 17:45 Opening 16.30 Plenary session 6 Plenary session 12 18:45 Welcome Reception 18.00 Drinks & Posters Closing & Drinks SUNDAY 11 DECEMBER 2016 11:00 REGISTRATION 13:00 - 14:15 Workshop round 1 13:00 - 14:15 Workshop 1: Medical Oncology - Methodology of clinical trails 13:00 Issues in the design of maintenance trials Dirk Arnold, CUF Cancer Centre, Portugal 13:15 Toxicity analysis of clinical trials Axel Grothey, Mayo Clinic, United States 13:30 The meaning of PFS as an endpoint Kees Punt, University of Amsterdam, the Netherlands 13:45 Cohort multiple randomized controlled trial design LennyVerkooijen, University Medical Centre Utrecht, the Netherlands 14:00 Discussion 13:00 - 14:15 Workshop 2: Surgical workshop - SurgicalTreatment of Metastatic Disease 13:00 Liver resection - How extensive and how minimally invasive? Peter Neumann, Uniklinik RWTH Aachen, Germany 13:15 State of the art treatment of peritoneal carcinomatosis Pompiliu Piso, University Hospital of Regensburg, Germany 13:30 Surgery for extrahepatic visceral metastases KeesVerhoef, Radboud University Medical Centre, the Netherlands 13:45 Discussion 13:00 - 14:15 Workshop 3: Radiation Oncology workshop - The role a local boost in the treatment of rectal cancer 13:00 Dose-response curves, brachy and external boost Ane Appelt, Rigshospitalet Vejle Hospital, Denmark 13:15 Intraluminal contact therapy Sun Myint, Clatterbridge Cancer Centre, United Kingdom 13:30 Trial external beam radiation Peter Burbach, University Medical Centre Utrecht, the Netherlands 13:45 Discussion 13:00 - 14:15 Workshop 4: Pathology workshop 13:00 DNA, stroma profiles Instituut Erik Hooijberg,VU University Medical Centre, the Netherlands 13:20 Scoring tumor infiltrate Petur Snaebjornsson, Netherlands Cancer Institute, the Netherlands 13:40 Discussion Programme at glance Scientific Programme
- 5. 13:00 - 14:15 Workshop 5: Genetics workshop 1 13:00 Microbioma and risk for CRC in Lynch syndrome Annemarie Boleij, Radboud University Medical Centre, the Netherlands 13:10 Testing for Lynch syndrome and other predisposition variants – a medical oncology perspective David Church, University of Oxford, United Kingdom 13:20 New guidelines on genetic testing in CRC T.b.a. 13:30 New genes for adenomatous polyposis and predisposition to CRC Roland Kuiper, Radboud University Medical Centre, the Netherlands 13:40 Serrated Polyposis Thomas Huw, Imperial College London, United Kingdom 13:50 Discussion 13:00 - 14:15 Workshop6:ImagingworkshopColonandRectalCancerImaging 13:00 Local Staging Colon Cancer : CT and MRI Max Lahaye, Netherlands Cancer Institute, the Netherlands 13:15 MR imaging Doenja Lambregts, Maastricht University Medical Centre, the Netherlands 13:30 Endorectal ultrasonography and elastography evaluation of rectal tumors JoWaage, Haukeland University Hospital, Norway 13:45 Distant staging of CRC : Optimal algorithm Christoph Zech, Basel University hospital, Switzerland 14:00 Discussion 14:15 BREAK 14:45 - 16:00 Workshops round 2 RepeatWorkshop 1 RepeatWorkshop 2 RepeatWorkshop 3 RepeatWorkshop 4 RepeatWorkshop 5 RepeatWorkshop 6 16:00 - 17:30 Sponsored symposium See page 15 for detailed information 17:45 OPENING 18:00 WELCOME RECEPTION MONDAY 12 DECEMBER 2016 08:00 REGISTRATION 08:00 - 10:00 Interactive computerized radiology workshop 08:15 - 09:30 Session 1: Follow-up 08:15 New data uit PROFILES registry Lonneke van de Poll-Franse,Tilburg University, the Netherlands 08:40 Frequency of surveillance T.b.a. 09:05 CEAWatch trial CharlotteVerberne, University Medical Centre Groningen, the Netherlands 09:30 - 10:45 Session 2: Health economics and quality of care 09:30 Magnitude of clinical benefit of colorectal cancer drugs T.b.a. 09:55 Variations in patterns of CRC care - which lessons can be learned? T.b.a. 10:20 Long term surgical morbidity and reintervention after rectal cancer treatment; a snapshot population based analysis PieterTanis, Academic Medical Centre, the Netherlands 10:45 BREAK 11:15 - 12:30 Session 3: Updated results from phase 3 trials 11:15 The FACS trial: the role of CT and CEA in colorectal cancer follow up John Primrose, Southampton General Hospital, United Kingdom 11:30 CREST trial (stent as bridge to surgery versus acute resection) James Hill, University of Colorado Health Sciences Centre, United States 11:45 The German CAO/ARO/AIO-04 study Claus Rodel, University of Frankfurt, Germany 12:00 Translational research CAIRO3 study Miriam Koopman, University Medical Centre Utrecht, the Netherlands 12:15 New EPOC trial John Primrose, Southampton General Hospital, United Kingdom 12:30 LUNCH POSTERS Scientific ProgrammeScientific Programme
- 6. 12:45 - 13:45 Sponsored Symposium 2 See page 15 for detailed information 14:00 - 14:45 Key-note lecture:The genomic landscape of colorectal cancer T.b.a. 14:45 - 15:15 Session 4:Translational research 14:45 Radiomics: there is more than meets the eye Philippe lambin, MAASTRO clinic, the Netherlands 15:00 Relation tumor and stroma Onno Kranenburg, University Medical Centre Utrecht, the Netherlands 15:15 - 16:00 Session 5: Controversy 1 15:15 PRO || Oxaliplatin has a role in the (neo)adjuvant treatment of locally advanced rectal cancer Dirk Arnold, CUF Cancer Centre, Portugal 15:30 CON || Oxaliplatin has a role in the (neo)adjuvant treatment of locally advanced rectal cancer David Sebag-Montefiore, University of Leeds, United Kingdom 15:45 - 16:00 Discussion 16:00 BREAK 16:30 - 17:50 Session 6: Multidisciplinary management 1 16:30 Whole body imaging for detection of distant metastases: what’s new? VincentVandecaveye, University Hospitals Leuven, Belgium 16:50 Treatment of screen detected early colon and rectal cancers Roel Hompes, University of Oxford, United Kingdom 17:10 Anti-VEGF versus anti-EGFR antibodies in RAS wildtype metastatic CRC: what are the data? Axel Grothey, Mayo Clinic, United States 17:30 Role of SIRT in the management of CRC liver metastases Thomas Helmberger, Institute for Diagnostic and Interventional Radiology München, Germany 18:00 DRINKS POSTERS TUESDAY 13 DECEMBER 2016 08:00 REGISTRATION 08:00 - 10:00 Interactive computerized radiology workshop 08:15 - 09:30 Session 7: Prevention and screening 08:15 Taiwan: data from the nationwide CRC screening programme (10 years experience) Chiu Han-Mo, NationalTaiwan University Hospital,Taiwan 08:40 Screening uptake and socioeconomic status T.b.a. 09:05 Biomarker tests for screening of colorectal cancer:What is on the horizon? Gerrit Meijer, Netherlands Cancer Institute, the Netherlands 09:30 - 10:45 Session 8: Genetics 09:30 Germline genetic testing form targeted testing to panel testing Maurizio Genuardi, University of the Sacred Heart, Italy 09:45 Genetic risk communication in daily practice Jan Oosterwijk, University Medical Centre Groningen, the Netherlands 10:00 Adding a family history to population CRC screening Nicoline Hoogerbrugge, Radboud University Medical Centre, the Netherlands 10:15 NGS in germline or somatic testing T.b.a. 10:30 Characterization of unclassified MMR gene variants Hein te Riele, Netherlands Cancer Institute, the Netherlands 10:45 BREAK 11:15 - 12:30 Session 9: Colorectal cancer and the immune system 11:15 Principles of immunotherapy Erik Hooijberg,VU university medical cente, the Netherlands 11:45 Current status and future prospects of immunotherapy in colorectal cancer T.b.a. 12:30 LUNCH POSTERS 12:45 - 13:45 Sponsored Symposium 2 See page 15 for detailed information Scientific ProgrammeScientific Programme
- 7. Scientific Programme 14:00 - 15:15 Session 10: Rectal cancer surgery 14:00 A patient tailored approach to low rectal cancer Yves Panis, Hôspital Beaujon Paris, France 14:25 Is there still an oncological safety issue in laparoscopic rectal cancer surgery? T.b.a. 14:25 TransanalTME as the step forward in minimally invasive rectal cancer surgery JurriaanTuynman,VU university medical cente, the Netherlands 15:15 - 16:00 Session 11: Controversy 2 15:15 PRO ||Wait and see after clinical complete response following chemoradiotherapy for rectal cancer is an acknowledged treatment option Geerard Beets, Netherlands Cancer Institute, the Netherlands 15:15 CON ||Wait and see after clinical complete response following chemoradiotherapy for rectal cancer is an acknowledged treatment option Rob Glynne-Jones, MountVernon Cancer Centre, United Kingdom 15:40 PRO || Improving complete responders of chemo-radiotherapy, role of systamic therapy Julio Garcia Aguilar, Memorial Sloan Kettering Cancer Cente, United States 15:40 CON || Improving complete responders of chemo-radiotherapy, role of systamic therapy VincenzoValentini, Catholic University of the Sacred Heart, Italy 16:00 BREAK 16:30 - 17:50 Session 12: Interval colorectal cancer: from nomenclature to benchmarking 16:30 Interval CRC:What andWhy? Silvia Sanduleanu, Maastricht University Medical Centre, the Netherlands 16:50 Interval cancer after colonoscopy - data from the Bowel Cancer Screening Program Matthew Rutter, NHS FoundationTrust, United Kingdom 17:10 Interval cancers: Can we avoid them? Chiu Han-Mo, NationalTaiwan University Hospital,Taiwan 17:30 The molecular secrets of interval cancers Beatriz Carvalho, Netherlands Cancer Institute, the Netherlands 18:00 CLOSING DRINKS Abstract deadline Thursday 1 September 2016, 10.00hrs. CET (Central EuropeanTime) The EMCCC Scientific Committee would like to encourage authors to submit their abstracts through the congress website.The online submission module is available at: www.emccc2016.org. Please check the conference website for the submission guidelines and read them carefully before submitting your abstract. Late breaker abstracts Late breaker abstracts will only be considered if there is new information on surgery, medical oncology, radiotherapy, pathology, imaging, gasttoenterology, and genetics that should be brought to the attention of conference because it is timely and will likely have an impact on the conference topics and the CRC community at large. Late breaking abstracts can be sent until 1 November 2016. Information on submission will be published as of 1 October 2016. Important dates for authors 1 September 2016 Abstract submission deadline 1 October 2016 Abstract notifications mailed 15 October 2016 Abstract presenter registration deadline 1 November 2016 Deadline late breaking abstracts Registration Registration fees Early Bird Regular Late (until 1 July ‘16) (2 July -1 October ‘16) (as of 2 October ‘16) Physicians academics EUR 475 EUR 675 EUR 795 Physicians academics in training EUR 295 EUR 395 EUR 495 Emerging economy rate EUR 175 EUR 200 EUR 200 What is included in the registration fee? The registration fee for delegates includes: admission to the meeting, welcome reception, programme and abstract book, e-certificate of attendance, 2 lunches and all coffee breaks. Congress dinner Monday Dinner tickets are available at the price of EUR 75. Please make your reservation when you register online. * Please check the website www.emccc2016.org for terms and conditions of registration. Registration payment Registration is possible via the congress website. Payment can be done online (all regular credit cards and SEPA direct debit). Group registrations For group registrations please contact the congress secretariat via: [email protected]. Group registration is available for groups of 5 participants or more. Call for abstracts / RegistrationScientific Programme
- 8. CME Accreditation Accreditation is applied for at the EuropeanAccreditationCouncil forContinuing Medical Education (EACCME). This accreditation will be endorsed by the European Union of Medical Specialists (UEMS) ensuring that the CME credits awarded to the participants are recognized by the national medical authorities who have agreed to co-operate in this European system. EACCME credits are recognized by theAmerican MedicalAssociation towards the Physician’s RecognitionAward (PRA). Venue The congress will be held in the RAI Congress Centre, Amsterdam, the Netherlands. www.rai.nl Exhibition sponsored symposia A targeted group of biotechnical and pharmaceutical companies will be invited to organize a sponsored integrated symposium and or exhibit their products and services. Language The official congress language will be English. No simultaneous translation will be available. Letter of invitation The organizers will be pleased to send a letter of invitation to any individual requesting one, once their registration form and fee have been received. It is to be understood that such an invitation is intended to help potential participants raise travel funds or obtain a visa. It is not a commitment on the part of the congress to provide any financial support. Applications have to be received by the conference secretariat before 1 October 2016. A refused visa application is no reason for refund. Insurance In registering for the EMCCC2016 delegates agree that neither the organization nor the congress agency Congress Care is responsible for individual medical, travel or personal insurance. Delegates are requested to arrange their own travel and health insurance. The organizers cannot assume liability for changes in the programme due to external circumstances. Website Please check de website www.emccc2016.org for more relevant information and (programme) updates. Sunday 11 December 2016 16:00 Sponsored symposium 1 Organised by Servier Monday 12 December 2016 12:45 Sponsored symposium 2 Tuesday 13 December 2016 12:45 Sponsored symposium 3 Sponsors EMCCC 2016 Major sponsors Sponsors General information Integrated Sponsored Symposia
- 9. Congress secretariat Congress Care PO Box 440 NL-5201 AK ‘s-Hertogenbosch T: +31 (0)73 690 1415 info@congresscare www.congresscare.com WWW.EMCCC2016.ORG